Hermes de Jesus Garban - Feb 14, 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Medical Officer
Signature
By: /s/ Hermes de Jesus Garban
Stock symbol
VINC
Transactions as of
Feb 14, 2022
Transactions value $
$0
Form type
4
Date filed
2/16/2022, 03:11 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +55.3K $0.00 55.3K Feb 14, 2022 Common Stock 55.3K $6.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests over three years, with 1/3 of the shares vesting on March 1, 2023, and 1/36th of the shares vesting monthly thereafter.